Metadata
Author: Literature
Data
English[en]
Imatinib mesylate specifically inhibits the tyrosine kinase activity of the bcr/abl oncogene.
Spanish[es]
El mesilato de imatinib inhibe de manera específica la actividad de la tirosina cinasa del oncogén bcr/abl.